The foregoing data, coupled with the prognostic power exhibited by the levels of VAV2 mRNA transcripts in hnSCC patients (Fig. 1b), suggested that the Vav2Onc-regulated gene expression landscape could be used to develop better prognostic tools for this tumor type. This evidence concerns the gene VAV2 and neoplasm.